- Home
- SVRA vs ALTI Comparison
SVRA vs ALTI Comparison
Compare SVRA & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ALTI
- Stock Information
- Founded
- SVRA 2007
- ALTI 2020
- Country
- SVRA United States
- ALTI United States
- Employees
- SVRA N/A
- ALTI N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- SVRA Health Care
- ALTI Finance
- Exchange
- SVRA Nasdaq
- ALTI Nasdaq
- Market Cap
- SVRA 527.2M
- ALTI 438.7M
- IPO Year
- SVRA N/A
- ALTI N/A
- Fundamental
- Price
- SVRA $3.72
- ALTI $4.14
- Analyst Decision
- SVRA Buy
- ALTI
- Analyst Count
- SVRA 7
- ALTI 0
- Target Price
- SVRA $6.00
- ALTI N/A
- AVG Volume (30 Days)
- SVRA 1.8M
- ALTI 103.5K
- Earning Date
- SVRA 08-13-2025
- ALTI 11-07-2025
- Dividend Yield
- SVRA N/A
- ALTI N/A
- EPS Growth
- SVRA N/A
- ALTI N/A
- EPS
- SVRA N/A
- ALTI N/A
- Revenue
- SVRA N/A
- ALTI $217,760,000.00
- Revenue This Year
- SVRA N/A
- ALTI $19.78
- Revenue Next Year
- SVRA N/A
- ALTI $7.00
- P/E Ratio
- SVRA N/A
- ALTI N/A
- Revenue Growth
- SVRA N/A
- ALTI N/A
- 52 Week Low
- SVRA $1.89
- ALTI $2.33
- 52 Week High
- SVRA $4.70
- ALTI $5.00
- Technical
- Relative Strength Index (RSI)
- SVRA 82.61
- ALTI 43.70
- Support Level
- SVRA $3.19
- ALTI $4.14
- Resistance Level
- SVRA $3.28
- ALTI $4.32
- Average True Range (ATR)
- SVRA 0.17
- ALTI 0.18
- MACD
- SVRA 0.04
- ALTI -0.02
- Stochastic Oscillator
- SVRA 88.36
- ALTI 12.85
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.